| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa8bc51073f246cc40be59c3422fd26f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-18122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16052 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2017-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0823701962d7a441f3ba63ed085515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11c230d6aaaef0ebdae002efa4662ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d4989c773470f6373651b776007690 |
| publicationDate |
2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109562150-A |
| titleOfInvention |
Viral particles for the transfer of RNA to cells especially involved in immune responses |
| abstract |
The present invention relates to retroviral particles comprising a protein from a Gag polyprotein, an envelope protein, optionally an integrase and at least two encapsidated non-viral RNAs each comprising target RNA sequences that bind to encapsidation sequences, each encapsidation sequence recognized by a binding domain incorporated into the protein from the Gag polyprotein and/or integrase; and, the encapsidated non-viral RNA At least one target sequence comprises a portion encoding at least one epitope and/or at least one molecular structure that specifically recognizes the epitope. |
| priorityDate |
2016-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |